Mardia Samyoung Capillary Tubes Company Ltd vs Rajputana Investment Finance Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Mardia Samyoung Capillary Tubes Company Ltd is ₹ 51.94 as of 30 Oct 15:30 . The P/E Ratio of Mardia Samyoung Capillary Tubes Company Ltd changed from 5.3 on March 2025 to 301.2 on March 2026 . This represents a CAGR of 653.86% over 2 yearsThe P/E Ratio of Rajputana Investment & Finance Ltd changed from 397.5 on March 2021 to 240.8 on March 2026 . This represents a CAGR of -8.01% over 6 years The Market Cap of Mardia Samyoung Capillary Tubes Company Ltd changed from ₹ 1.32 crore on March 2021 to ₹ 673.4 crore on March 2026 . This represents a CAGR of 182.67% over 6 yearsThe Market Cap of Rajputana Investment & Finance Ltd changed from ₹ 4.9 crore on March 2021 to ₹ 9.64 crore on March 2026 . This represents a CAGR of 11.94% over 6 years The revenue of Mardia Samyoung Capillary Tubes Company Ltd for the Sep '26 is ₹ 23.38 crore as compare to the Jun '26 revenue of ₹ 24.84 crore. This represent the decline of -5.88% The revenue of Rajputana Investment & Finance Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 1.51 crore. This represent the decline of -100% The ebitda of Mardia Samyoung Capillary Tubes Company Ltd for the Sep '26 is ₹ 1.3 crore as compare to the Jun '26 ebitda of ₹ 1.42 crore. This represent the decline of -8.45% The ebitda of Rajputana Investment & Finance Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0.02 crore. This represent the decline of -100% The net profit of Mardia Samyoung Capillary Tubes Company Ltd changed from ₹ -0.18 crore to ₹ 0.98 crore over 10 quarters. This represents a CAGR of NaN% The net profit of Rajputana Investment & Finance Ltd changed from ₹ 0.14 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The Dividend Payout of Mardia Samyoung Capillary Tubes Company Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Rajputana Investment & Finance Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Mardia Samyoung Capillary Tubes Company Ltd

Mardia Samyoung Capillary Tubes Company Limited, a Joint Venture between Mardia Group Companies i.e., Mardia Extrusions & Mardia Tubes and Samyoung Jung Kwan Company of South Korea was incorporated in October, 1992.
Initially, the Company was engaged in manufacture of capillary and thin-walled pipes and tubes made from brass, stainless steel, copper and other copper alloys.
The foreign collaborator holds 25% stake in the Company.
At present, the Company is engaged in manufacture of non-ferrous metals. The foreign collaborator Samyoung, S.Korea has agreed to buy 6000 tpa of the finished products of the company apart from providing financial and technical collaboration.
The company's manufacturing facility with an installed capacity of 1800 tpa is located in Silvassa.

About Rajputana Investment & Finance Ltd

Rajputana Investment & Finance Limited, was incorporated on September 23, 1941.
Company deals with the business of sale of re-owned luxury cars and related activities.
Besides, it deals with and invest the surplus funds of the Company or in its custody in such manner and in such securities as shall from time to time be thought necessary for the benefit of the Company. The Company entered into new Textile & Clothing business during the Financial Year 2014-15. During financial year 2014-15, Deepshika Infra India Limited, Independent Realty India Limited, Satyamev Properties Limited, Secure Jewellers Limited, Surestep Realtors Limited and Ventrux Enclave Limited became subsidiaries of the Company. Pursuant to Share Purchase Agreement and the applicable SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011, there was a change in management of July 31, 2018.

FAQs for the comparison of Mardia Samyoung Capillary Tubes Company Ltd and Rajputana Investment & Finance Ltd

Which company has a larger market capitalization, Mardia Samyoung Capillary Tubes Company Ltd or Rajputana Investment & Finance Ltd?

Market cap of Mardia Samyoung Capillary Tubes Company Ltd is 412 Cr while Market cap of Rajputana Investment & Finance Ltd is 8 Cr

What are the key factors driving the stock performance of Mardia Samyoung Capillary Tubes Company Ltd and Rajputana Investment & Finance Ltd?

The stock performance of Mardia Samyoung Capillary Tubes Company Ltd and Rajputana Investment & Finance Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mardia Samyoung Capillary Tubes Company Ltd and Rajputana Investment & Finance Ltd?

As of November 1, 2026, the Mardia Samyoung Capillary Tubes Company Ltd stock price is INR ₹51.94. On the other hand, Rajputana Investment & Finance Ltd stock price is INR ₹28.5.

How do dividend payouts of Mardia Samyoung Capillary Tubes Company Ltd and Rajputana Investment & Finance Ltd compare?

To compare the dividend payouts of Mardia Samyoung Capillary Tubes Company Ltd and Rajputana Investment & Finance Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.